Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Lipitor (atorvastatin) for prevention of stroke in patients who have had a prior stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipitor (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Cardiovascular Disease | Phase 4 | Status: COMPLETED